title: Intensive therapy for high grade multiple myeloma (MM).
authors.affiliation: Department of Hematology, Hotel Dieunantes, France.
authors.forename: J L
authors.initials: JL
authors.lastname: Harousseau
authors.forename: N
authors.initials: N
authors.lastname: Milpied
authors.forename: J P
authors.initials: JP
authors.lastname: Jouet
authors.forename: P
authors.initials: P
authors.lastname: Colombat
authors.forename: F
authors.initials: F
authors.lastname: Guilhot
authors.forename: J P
authors.initials: JP
authors.lastname: Laporte
authors.forename: N
authors.initials: N
authors.lastname: Ifrah
authors.forename: C
authors.initials: C
authors.lastname: Gandhour
authors.forename: P
authors.initials: P
authors.lastname: Casassus
mesh_terms: D000328:Adult; D000368:Aged; D016026:Bone Marrow Transplantation / Q000401:mortality; D003131:Combined Modality Therapy; D005602:France / Q000453:epidemiology; D006801:Humans; D008558:Melphalan / Q000627:therapeutic use*; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy / Q000401:mortality / Q000601:surgery*; D012074:Remission Induction; D015996:Survival Rate
chemical_list: D008558:Melphalan